热门资讯> 正文
STAAR外科表示,除了Alcon之外,没有其他无罪释放提案
2025-10-17 04:58
- STAAR Surgical (NASDAQ:STAA) said it has not received any proposal to acquire the company other than from Alcon (NYSE:ALC), including the 45-day "window shop" period.
- "As previously disclosed, the communications from Party A and B were not offers and contained no information relating to valuation, timing, diligence requirements, financing capability, transaction structure, or other terms," STAAR Surgical said in a statement on Thursday. The outreach from parties A, B and C were not offers.
- The latest comments from STAAR Surgical (NASDAQ:STAA) come after prominent proxy adviser ISS said holders should vote against Alcon's (NYSE:ALC) planned $1.5 billion purchase of the implantable lens maker. Fellow proxy firm Glass Lewis last week also recommended shareholders vote against the transaction. A vote on the deal is set for Oct. 23.
More on STAAR Surgical, Alcon
- Alcon: Seeing Is Believing As Buyout Of STAAR Surgical Hangs In Balance
- Alcon Inc. (ALC) Presents at Baird Global Healthcare Conference 2025 - Slideshow
- Alcon Inc. 2025 Q2 - Results - Earnings Call Presentation
- STAAR Surgical holders should vote against sale to Alcon, ISS says (update)
- STAAR Surgical holders should vote against sale to Alcon, Glass Lewis says
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。